Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Followers

62 Following

Tom Powles (@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

5 years ago

A new chapter for bladder cancer patients with a new class of drug. Enfortmab vedotin extending overall survival and progression free survival in randomised trials post IO and chemo. Both clinically meaningful - details in press release. #esmo20 . astellas.com/us/news/5176

A new chapter for bladder cancer patients with a new class of drug. Enfortmab vedotin extending overall survival and progression free survival in randomised trials post IO and chemo. Both clinically meaningful - details in press release. #esmo20 . astellas.com/us/news/5176